Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Nature Reviews. Microbiology|June 17, 2010
Structure-based discovery of antibacterial drugsKatie J Simmons, Ian Chopra, Colin W G FishwickScientific Reports|February 19, 2021
Affinity-based proteomics reveals novel binding partners for Rab46 in endothelial cellsLucia Pedicini, Sabina D Wiktor, Katie J Simmons, et al.Chemical Biology & Drug Design|July 1, 2014
Computational methods to identify new antibacterial targetsMartin J McPhillie, Ricky M Cain, Sarah Narramore, et al.International Journal of Molecular Sciences|August 10, 2024
Identification of Ribonuclease Inhibitors for the Control of Pathogenic BacteriaRute G Matos, Katie J Simmons, Colin W G Fishwick, et al.Communications Biology|November 26, 2025
Adhirons are efficient tools to guide antiviral ligand discoveryAlex J Flynn, Alex Derry, Oliver Debski-Antoniak, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 21, 2024
Using site-directed mutagenesis to further the understanding of insulin receptor-insulin like growth factor-1 receptor heterodimer structureSamuel Turvey, Stephen P Muench, Tarik Issad, et al.Communications Biology|November 24, 2020
Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding siteDavid J Wright, Katie J Simmons, Rachel M Johnson, et al.European Journal of Medicinal Chemistry|May 2, 2026
Large-scale structure-based virtual screening identifies diverse KNa1.1 (KCNT1) potassium channel inhibitorsEmily A Caseley, Katie J Simmons, Bethan A Cole, et al.Proceedings of the National Academy of Sciences of the United States of America|February 16, 2017
Extending enzyme molecular recognition with an expanded amino acid alphabetClaire L Windle, Katie J Simmons, James R Ault, et al.RSC Medicinal Chemistry|June 1, 2022
Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulatorsSamuel J Turvey, Martin J McPhillie, Mark T Kearney, et al.Pageof 3